Q3 2025 Management View Brian Carrico, President, CEO & Director, emphasized "the continued execution of our commercialization strategy for IB-Stim, our neuromodulation technology for both the ...
Discover how STRATA Skin Sciences' CPT code expansion aims to triple its market by 2027. Get Q3 results, growth insights, and future outlook.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback